Study confirms link between SABA inhalers and asthma exacerbations
High SABA inhaler use was associated with around twice the number of exacerbations, the SABINA study found
Read More
Tag: exacerbations
AZ’ triple combo hits endpoint in COPD trial
Breztri Aerosphere – formerly known as PT010 – showed a 52% reduction in exacerbations.
Read More
Owlstone, Imperial College London link on asthma study
UK diagnostics group Owlstone Medical has formed a pact with Imperial College London allowing use of its breath analysis technology in a study assessing the underlying causes of exacerbations in severe asthma patients.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
